Skip to main content
. 2021 Mar 29;36(11):1694–1700. doi: 10.1007/s00380-021-01843-w

Table 3.

Median values of daily remote monitoring transmissions in period I (1 month pre-lockdown) and II (1 month post-lockdown) in patients aged <70 years (n = 81) and aged ≥70 years (n = 99)

Patients aged < 70 years Patients aged ≥ 70 years
Period I (1 month pre-lockdown) Period II (1 month post-lockdown) p value Period I (1 month pre-lockdown) Period II (1 month post- lockdown) p value
RM daily transmission rate (%) 97.0 (88.5–100) 97.0 (95.5–100) 0.109 97.0 (93.0–100) 97.0 (97.0–100) 0.177
Physical activity (%) 16.1 (10.8–21.6) 11.4 (8.6–15.2) < 0.001 10.6 (6.7–16.2) 8.2 (4.5–11.7) < 0.001
Thoracic impedance (ohm) 74.5 (66.5–78.8) 75.2 (69.0–79.5) < 0.001 73.8 (66.3–80.5) 74.6 (66.7–82.0) 0.013
Mean heart rate (bpm) 71.3 (65.1–78.8) 68.1 (62.8–76.8) < 0.001 67.2 (63.2–73.8) 67.8 (62.0–74.0) < 0.001
Resting heart rate (bpm) 60.2 (52.2–67.9) 58.0 (52.1–66.1) < 0.001 60.0 (54.6–65.4) 60.0 (54.7–67.2) 0.402
Frequency of PVCs (n/hour) 0.4 (0–40.5) 0.1 (0–31.6) 0.365 5.7 (0–68.7) 1.6 (0.1–68.4) 0.448
Atrial pacing percentage (%) 8.9 (0.1–23) 10.8 (0.4–30.7) 0.012 23.1 (0.5–57.8) 18.3 (0.6–56.6) 0.815
Right ventricular pacing percentage (%) 0.3 (0–4.6) 0.3 (0–4.4) 0.696 11.1 (0.2–97.2) 10.5 (0.3–96.4) 0.946
CRT pacing percentage (%) 96.0 (95.1–99.8) 98.7 (93.6–100) 0.528 98.6 (94.7–99.9) 98.9 (96.7–100) 0.048
PP variability (ms) 93.9 (69.1–114.7) 89.9 (71.6–112.7) 0.120 70.1 (36.5–86.7) 70.9 (38.1–88.9) 0.673
Number of patients with AF episodes n (%) 7 (11.9) 9 (15.2) 0.591 11 (16.7) 10 (15.1) 0.812
24 h AF burden*(%) 99.9 (0.4–100) 99.9 (4.4–100) 0.048 100 (17.5–100) 100 (4.1–100) 0.723
Number of patients with ATP n (%) 1 (1.3) 1 (1.3) 1.000 2 (2.1) 2 (2.1) 1.000
Number of patients with shock, n (%) 1 (1.3) 2 (2.5) 0.560 0 (0) 3 (1.0) 0.316

Data are shown as median (interquartile range) and n (%) for binary variables

RM remote monitoring, PVC pre-ventricular contraction, CRT cardiac resynchronization therapy, AF atrial fibrillation, ATP anti-tachycardia pacing

aConsidering only patients with at least one AF episode